[On appearance of physical dependence and analgesic activity of 2-(5H-[1]- benzopyrano[2,3-b]pyridin-7-yl)propionic acid (Y-8004) by repeated administration (author's transl)].
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D007977:Levallorphan / Q000037:antagonists & inhibitors; D008297:Male; D051379:Mice; D009020:Morphine / Q000037:antagonists & inhibitors; D011422:Propionates / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D011725:Pyridines / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D051381:Rats; D019966:Substance-Related Disorders
D000894:Anti-Inflammatory Agents, Non-Steroidal; D011422:Propionates; D011725:Pyridines; D007977:Levallorphan; D009020:Morphine